Geneos Wealth Management’s Protolabs PRLB Stock Holding History
Bought
Maintained
Sold
Other funds holding PRLB
DGI
NAMA
BCM
AIM
Geneos Wealth Management's PRLB Position: Q3 2022 in Review
Geneos Wealth Management sold out of Protolabs (PRLB) in Q3 2022, closing a stake of 50 shares — an estimated $2K sold.
Geneos Wealth Management first reported a position in PRLB in Q1 2016 and held it in 26 quarters. The position peaked at $24K in Q3 2018. 210 funds tracked by Wall St. Rank hold PRLB as of Q3 2022.
- Geneos Wealth Management reported no remaining Protolabs position as of Q3 2022 after selling out during the quarter.
- Geneos Wealth Management sold 50 Protolabs shares in Q3 2022, an estimated $2K.
- Geneos Wealth Management first reported a position in Protolabs in Q1 2016 and held it in 26 quarters.
- Geneos Wealth Management's Protolabs position peaked at $24K in Q3 2018.
- 210 funds tracked by Wall St. Rank held Protolabs as of Q3 2022.
Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.